glp 1 stories The GLP-1 Story... (a GoggleDocs Podcast) GLP-1 Drugs: 6 Things We've

Researchers working with multiple peptides simultaneously should be particularly careful about labeling

Drug formularies may cover GLP-1 agonists prescribed for Type 2 diabetes but not for weight loss

It is a self-reinforcing cycle that is hard to interrupt with any single intervention

All we're proposing to clinicians is Hey, think about the patients who are at risk and have a strategy to monitor and mitigate that risk." In a secondary analysis, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play

Acknowledgements This work was partially supported by grants from JSPS (KAKENHI Grant Numbers JP21K08032 and 24K11270) to KS